Clinical Trial Update: Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer

View source ↗

Summary

AstraZeneca is conducting a clinical trial to evaluate an AI-based screening tool that predicts genetic risk for breast cancer, and the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Neoplasms | Status: RECRUITING